We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...

Viking Therapeutics VKTX has outperformed the market over the past 5 years by 22.07% on an annualized basis producing an ...

Equities researchers at William Blair decreased their Q1 2025 earnings per share estimates for shares of Viking Therapeutics in a research note issued to investors on Wednesday, February 5th. William ...

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The ...

On Thursday, Truist Securities reaffirmed its Buy rating and $120.00 price target for Viking Therapeutics (NASDAQ:VKTX) stock. The positive stance comes as competitor ...

The 49ers are at +350. (If you trust us on anything, trust us on this — he will not be a 49er.) Next come the Vikings (please, God, no) at +400, the Titans at +750, and the Colts at +850. The Rams ...